NCT05855291View on ClinicalTrials.gov

PET/MRI in Predicting the Outcome of Neoadjuvant Chemoradiotherapy With Esophagectomy in Esophageal Cancer Patients

NACompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

January 22, 2018

Primary Completion Date

July 31, 2021

Study Completion Date

July 31, 2021

Conditions
Esophageal Cancer
Interventions
DIAGNOSTIC_TEST

PET/MRI

The participants receive 18F-FDG PET/MRI before and after neoadjuvant chemoradiotherapy.

Trial Locations (1)

Unknown

Linkou Chang Gung Memorial Hospital, Taoyuan District

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER

NCT05855291 - PET/MRI in Predicting the Outcome of Neoadjuvant Chemoradiotherapy With Esophagectomy in Esophageal Cancer Patients | Biotech Hunter | Biotech Hunter